Friday, December 24, 2010

From Harvard: ERCC2/XPD polymorphisms and lung cancer risk

http://www.ncbi.nlm.nih.gov/pubmed/21178723

J Thorac Oncol. 2011 Jan;6(1):233.
ERCC2/XPD Polymorphisms and Lung Cancer Risk.
Christiani DC.

Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Harvard School of Public Health, Boston, Massachusetts.

No comments:

Post a Comment